Clinical trial
A Preliminary Evaluation of Fanconi Syndrome Due to Antiretroviral Therapies in HIV-Infected Persons
NCT00499187 is registered in ClinicalTrials.gov with Gilead Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Preliminary Evaluation of Fanconi Syndrome Due to Antiretroviral Therapies in HIV-Infected Persons
- Lead sponsor
- Gilead Sciences
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 30, 2007
- Completion date
- March 31, 2011
- Enrollment
- 56 (actual)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.
fanconi syndrome, hiv infections, kidney disease, renal impairment